News & Videos - ITL HEALTH GROUP LIMITED

You are currently viewing all stock exchange news of the financial instrument ITL HEALTH GROUP LIMITED regarding all markets in all languages.

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL BioMedical Launches "ITL Clinical", a New Brand to Target Hospital and Clinical Markets • • PR Newswire • Stocks

ITL BioMedical Launches "ITL Clinical", a New Brand to Target Hospital and Clinical Markets PR Newswire MELBOURNE, Australia, Nov. 14, 2017 MELBOURNE, Australia , Nov. 14, 2017 /PRNewswire/ -- ITL BioMedical , a division of ITL Health Group (ASX: ITD), that creates and manufacturers leading edge medical devices for the clinical, blood banking and laboratory markets, is pleased to announce the launch of a new global brand, ITL Clinical, that will feature ITL products that serve the hospital and...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL Limited Rebrands to ITL Health Group to Unify Divisions under a Global Brand • • PR Newswire • Stocks

ITL Limited Rebrands to ITL Health Group to Unify Divisions under a Global Brand PR Newswire MELBOURNE, Australia, Feb. 28, 2017 MELBOURNE, Australia , Feb. 28, 2017 /PRNewswire/ -- ITL Limited ( ASX:ITD ), an innovative global medical technology company, supplier and strategic partner that provides innovative products and solutions to healthcare markets and empowers individual health management, formally announces its rebrand to ITL Health Group (ITL). The name change is part of the Company's...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

El beneficio de ITL se duplica para los resultados de mitad de año 2016/2017 • • PR Newswire • Stocks

El beneficio de ITL se duplica para los resultados de mitad de año 2016/2017 PR Newswire MELBOURNE, Australia, 24 de febrero de 2017 MELBOURNE, Australia , 24 de febrero de 2017 /PRNewswire/ -- ITL Limited, ( ASX: ITD ), una compañía sanitaria diversificada, se complace anunciar resultados excelentes para la primera mitad del año finalizado el 31 de diciembre de 2016 en comparación con el periodo anterior correspondiente. Una presentación completa de "Results and ITL BioMedical Growth...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL double ses profits dans ses résultats semestriels 2016/2017 • • PR Newswire • Stocks

ITL double ses profits dans ses résultats semestriels 2016/2017 PR Newswire MELBOURNE, Australie, le 24 février 2017 MELBOURNE , Australie, le 24 février 2017 /PRNewswire/ -- ITL Limited, ( ASX : ITD ), une société de soins de santé diversifiée innovante, est ravie d'annoncer les excellents résultats semestriels clos le 31 décembre 2016 par rapport à la période précédente correspondante. Une présentation complète « Résultats et mise à jour sur la croissance biomédicale d'ITL...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

Gewinn von ITL verdoppelt sich im Halbjahresergebnis 2016/2017 • • PR Newswire • Stocks

Gewinn von ITL verdoppelt sich im Halbjahresergebnis 2016/2017 PR Newswire MELBOURNE, Australien, 24. Februar 2017 MELBOURNE , Australien, 24. Februar 2017 /PRNewswire/ -- ITL Limited, ( ASX: ITD ), ein innovatives, diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum 31. Dezember 2016 endende Halbjahr im Vergleich mit dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. Eine vollständige Präsentation „Ergebnisse von ITL BioMedical und...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL Profit Doubles In Half Year 2016/2017 Results • • PR Newswire • Stocks

ITL Profit Doubles In Half Year 2016/2017 Results PR Newswire MELBOURNE, Australia, Feb. 24, 2017 MELBOURNE, Australia , Feb. 24, 2017 /PRNewswire/ -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare company, is pleased to announce excellent results for the half year ended 31 December 2016 compared with the previous corresponding period. A full "Results and ITL BioMedical Growth Update" presentation can be viewed here . Highlights Profit after tax of $2.12m ( Dec 2015 : $1.04m ;...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL Profit Doubles In Half Year 2016/2017 Results • • PR Newswire • Stocks

ITL Profit Doubles In Half Year 2016/2017 Results PR Newswire MELBOURNE, Australia, Feb. 23, 2017 MELBOURNE, Australia , Feb. 23, 2017 /PRNewswire/ -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare company, is pleased to announce excellent results for the half year ended 31 December 2016 compared with the previous corresponding period. A full "Results and ITL BioMedical Growth Update" presentation can be viewed here . Highlights Profit after tax of $2.12m ( Dec 2015 : $1.04m ;...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL Profit Doubles In Half Year 2016/2017 Results • • PR Newswire • Stocks

Thank you

ITL HEALTH GROUP LIMITED > News GlobeNewsWire published a news.

ITL Pharma Receives United States Patent Protection for TriThroid® Using Sustained Drug Release and Improved Product Stability • • GlobeNewsWire • Stocks

KINGSPORT, Tenn., Feb. 14, 2017 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS Research Company, today announced awarding of a United States Patent (US 9,526,701) titled: "Sustained Drug Release and Improved Product Stability Using Non-Covalent Particle Coating Methods." This "umbrella" patent provides a novel approach to drug delivery, allowing for extended product stability and controlled release of the API. TriThroid® (T3, Liothyronine, Na) is the lead product in the pipeline of products...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL BioMedical Announces Early Sales of Recently Launched New Product DonorCare® Needle Guard 2 • • PR Newswire • Stocks

ITL BioMedical Announces Early Sales of Recently Launched New Product DonorCare® Needle Guard 2 PR Newswire MELBOURNE, Australia, Nov. 16, 2016 MELBOURNE, Australia , Nov. 16, 2016 /PRNewswire/ -- ITL BioMedical , a division of ITL (ASX: ITD) that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has...

Thank you

ITL HEALTH GROUP LIMITED > News PR Newswire published a news.

ITL BioMedical Announces Global Launch of DonorCare® Needle Guard 2 • • PR Newswire • Stocks

ITL BioMedical Announces Global Launch of DonorCare® Needle Guard 2 PR Newswire MELBOURNE, Australia, Nov. 8, 2016 MELBOURNE, Australia , Nov. 8, 2016 /PRNewswire/ -- ITL BioMedical , a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce the global launch of its highly innovative patented DonorCare Needle Guard 2 that took place at the American Association of Blood Banks (AABB)...

Thank you